Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rom J Morphol Embryol ; 54(3): 545-54, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24068402

RESUMO

In this study, we aimed to determine EGF, c-erbB-2 and EGFR expression in 25 specimens of intestinal gastric adenocarcinomas by standardized immunohistochemistry and to establish correlations with the major clinico-morphological parameters of these patients. We observed EGF reactivity in 22 (88%) cases, a c-erbB-2 protein expression in eight (32%) cases and an EGFR reactivity in 13 (46.42%) cases. The EGF expression was significantly correlated with the tumor degree of differentiation, but not with other investigated clinico-morphological parameters and nor with c-erbB-2 and EGFR1 expression. However, we noticed the existence of a dependence between c-erbB-2 and EGFR1 expression in the main tumor mass. Such immunoprofile suggests the possible intervention of autocrine and paracrine loops in the developing of intestinal variant of gastric adenocarcinomas.


Assuntos
Adenocarcinoma/metabolismo , Receptores ErbB/biossíntese , Receptor ErbB-2/biossíntese , Neoplasias Gástricas/metabolismo , Adenocarcinoma/patologia , Fator de Crescimento Epidérmico/biossíntese , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/metabolismo , Humanos , Imuno-Histoquímica , Receptor ErbB-2/metabolismo , Neoplasias Gástricas/patologia
2.
Rom J Morphol Embryol ; 53(3 Suppl): 795-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23188442

RESUMO

In this study, we analyzed Ki67 and cyclin D1 immunoexpression in 44 oral squamous cell carcinomas from various anatomical sites. Ki67 immunoreaction was identified in all analyzed cases and presented an index of proliferation of 22% for well-differentiated carcinomas, 32% for moderately differentiated and 53% for the poorly differentiated ones. In case of cyclin D1, the mean positivity index was 8% for well-differentiated carcinomas, 18% for moderately differentiated and 34% for the poorly differentiated carcinomas. The analyzed biomarkers prove useful to identify lesions with poor differentiation and invasive behavior.


Assuntos
Carcinoma de Células Escamosas/metabolismo , Ciclina D1/metabolismo , Neoplasias de Cabeça e Pescoço/metabolismo , Antígeno Ki-67/metabolismo , Neoplasias Bucais/metabolismo , Adulto , Idoso , Carcinoma de Células Escamosas/patologia , Ciclina D1/biossíntese , Feminino , Neoplasias de Cabeça e Pescoço/patologia , Humanos , Antígeno Ki-67/biossíntese , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/patologia , Carcinoma de Células Escamosas de Cabeça e Pescoço
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA